Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Black Diamond Therapeutics Inc BDTX

Healthcare Biotechnology
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company focused on the development of MasterKey therapies that address families of oncogenic mutations in clinically validated targets. The Company’s MasterKey therapies are designed to address broad genetically defined patient populations, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat... see more

Recent & Breaking News (NDAQ:BDTX)

Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series

GlobeNewswire February 11, 2021

Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of Directors

GlobeNewswire January 20, 2021

Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare Conference

GlobeNewswire January 5, 2021

Black Diamond Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

GlobeNewswire November 24, 2020

Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting

GlobeNewswire November 20, 2020

Black Diamond Therapeutics to Present at the Jefferies 2020 Virtual London Healthcare Conference

GlobeNewswire November 11, 2020

Black Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire November 10, 2020

Black Diamond Therapeutics Presents Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual Symposium

GlobeNewswire October 26, 2020

Black Diamond Therapeutics to Present Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual Symposium

GlobeNewswire October 12, 2020

Black Diamond Therapeutics Announces the Appointment of Biopharmaceutical Veteran Robert A. Ingram as Chairman of the Board

GlobeNewswire September 29, 2020

Black Diamond Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference

GlobeNewswire September 10, 2020

Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical Officer

GlobeNewswire September 8, 2020

Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire August 11, 2020

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire August 5, 2020

Black Diamond Therapeutics Announces the Appointment of Fang Ni as Chief Business Officer

GlobeNewswire August 4, 2020

Black Diamond Therapeutics Granted Fast Track Designation by the FDA for BDTX-189 for the Treatment of Adult Patients with a Solid Tumor Harboring an Allosteric HER2 Mutation or an EGFR or HER2 Exon 20 Insertion Mutation

GlobeNewswire July 28, 2020

Black Diamond Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

GlobeNewswire June 16, 2020

Black Diamond Therapeutics to Present at the Jefferies Virtual Healthcare Conference

GlobeNewswire May 27, 2020

Black Diamond Therapeutics Announces Accepted Abstract for Lead Product Candidate BDTX-189 at American Society of Clinical Oncology 2020

GlobeNewswire May 13, 2020

Black Diamond Therapeutics Reports First Quarter 2020 Financial Results and Corporate Update

GlobeNewswire May 12, 2020